Spots Global Cancer Trial Database for muc1
Every month we try and update this database with for muc1 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Intervention of CAR-T Against Cervical Cancer | NCT03356795 | Cervical Cancer | Cervical cancer... | 18 Years - 70 Years | Shenzhen Geno-Immune Medical Institute | |
| Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer | NCT03540199 | Advanced Kidney... | Activated CIK a... cryotherapy | 18 Years - 75 Years | Fuda Cancer Hospital, Guangzhou | |
| MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers | NCT05986981 | Solid Tumor, Ad... | Vaccine | 18 Years - 75 Years | Peking Union Medical College Hospital | |
| STRIDE - STimulating Immune Response In aDvanced brEast Cancer | NCT00925548 | Breast Cancer | Tecemotide (L-B... Placebo of tece... cyclophosphamid... sodium chloride... | 18 Years - | EMD Serono | |
| Antigen-specific T Cells Against Lung Cancer | NCT03356808 | Lung Cancer | Lung cancer-spe... | 18 Years - 80 Years | Shenzhen Geno-Immune Medical Institute | |
| Phase 1 Study of ONT-10 in Patients With Solid Tumors | NCT01556789 | Solid Tumors | ONT-10 | 18 Years - 70 Years | Seagen Inc. | |
| Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer | NCT03540199 | Advanced Kidney... | Activated CIK a... cryotherapy | 18 Years - 75 Years | Fuda Cancer Hospital, Guangzhou | |
| Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer | NCT03484962 | Advanced Liver ... | Activated CIK a... cryotherapy | 18 Years - 75 Years | Fuda Cancer Hospital, Guangzhou | |
| Intervention of CAR-T Against Cervical Cancer | NCT03356795 | Cervical Cancer | Cervical cancer... | 18 Years - 70 Years | Shenzhen Geno-Immune Medical Institute | |
| Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast Cancer | NCT02270372 | Advanced Breast... Advanced Ovaria... | ONT-10, Varlilu... | 18 Years - | Seagen Inc. | |
| Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Lung Cancer | NCT03501056 | Advanced Lung C... | Activated CIK a... Cryotherapy | 18 Years - 75 Years | Fuda Cancer Hospital, Guangzhou | |
| A Study to Assess the Safety and Efficacy of MUC1 Peptide Vaccine and hGM-CSF in Patients With MUC1-positive Tumor Malignancies | NCT01232712 | Multiple Myelom... | ImMucin, hGM-CS... | 18 Years - | Vaxil Therapeutics Ltd. | |
| Targeted T-cell Therapy in Solid Tumors | NCT04076137 | Malignant Solid... | Targeted T-cell... | 18 Years - 75 Years | Benhealth Biopharmaceutical (Shenzhen) Co., Ltd. | |
| Phase 1 Study of ONT-10 in Patients With Solid Tumors | NCT01556789 | Solid Tumors | ONT-10 | 18 Years - 70 Years | Seagen Inc. | |
| Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer | NCT03484962 | Advanced Liver ... | Activated CIK a... cryotherapy | 18 Years - 75 Years | Fuda Cancer Hospital, Guangzhou | |
| GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers | NCT03198052 | Lung Cancer Cancer Immunotherapy CAR-T Cell | CAR-T cells tar... | 18 Years - 75 Years | Second Affiliated Hospital of Guangzhou Medical University | |
| Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer | NCT03524261 | Advanced Breast... | Activated CIK a... cryotherapy | 18 Years - 75 Years | Fuda Cancer Hospital, Guangzhou | |
| Phase 1b Maintenance Therapy Study of ONT-10 in Patients With Solid Tumors | NCT01978964 | Solid Tumors | ONT-10 | 18 Years - 70 Years | Seagen Inc. | |
| Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast Cancer | NCT02270372 | Advanced Breast... Advanced Ovaria... | ONT-10, Varlilu... | 18 Years - | Seagen Inc. | |
| Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Pancreatic Cancer | NCT03509298 | Advanced Pancre... | Activated CIK a... cryotherapy | 18 Years - 75 Years | Fuda Cancer Hospital, Guangzhou | |
| STRIDE - STimulating Immune Response In aDvanced brEast Cancer | NCT00925548 | Breast Cancer | Tecemotide (L-B... Placebo of tece... cyclophosphamid... sodium chloride... | 18 Years - | EMD Serono | |
| MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers | NCT05986981 | Solid Tumor, Ad... | Vaccine | 18 Years - 75 Years | Peking Union Medical College Hospital | |
| Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Colorectal Cancer | NCT03524274 | Advanced Colore... | Activated CIK a... Cryotherapy | 18 Years - 75 Years | Fuda Cancer Hospital, Guangzhou |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
